LabCompass

Yuxi Li

Medicine · Indiana University

Publications

74

Citations

1,363

Est. group size

Recurring co-author estimate

Active years

16

Publishing since 2011

Research summary
AI-generated

The publication record associated with this name spans a broad set of biomedical and chemical topics, including the pharmacology and toxicology of cannabidiol (a cannabis-derived compound), studies of reproductive biology and hormone-responsive cells, neuroscience of brain regions controlling body temperature and aversion, and the design and antimicrobial testing of new chemical compounds. Note that these papers cover very diverse fields and may reflect the work of more than one researcher sharing this name. Common threads include drug safety/toxicity testing and mechanistic studies in cells and animal models.

Cannabidiol pharmacology and toxicologyDrug safety and cytotoxicity testingReproductive and ovarian cell biologyNeuroscience of brain circuits (body temperature, aversion)Synthesis and antimicrobial activity of new compounds

Publication activity has grown over the past decade, rising from around one paper per year in 2017–2018 to double digits in recent years (16 in 2025), averaging about 9.6 per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 9.6/year recently
2017: 1 publication172018: 1 publication182019: 5 publications192020: 8 publications202021: 6 publications212022: 11 publications222023: 7 publications232024: 13 publications242025: 16 publications16252026: 1 publication26
Recent publications
Publishes in
  • Archives of Toxicology×4
  • Journal of Environmental Science and Health Part C×3
  • Research Square×3
  • Experimental & Molecular Medicine×2
  • Toxicological Sciences×2

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile